Co-Diagnostics Inc.
Co-Diagnostics Inc. (CODX) — Form 8-K: Current report
About this filing
Co-Diagnostics Inc. (CODX) filed an 8-K on Nov 20, 2026 reporting entry into a material agreement (Item 1.01), new debt or another financial obligation (Item 2.03) and an unregistered sale of shares (Item 3.02), with exhibits (Item 9.01).
Key facts
- Item 1.01 · Entry into a material agreement
- Item 2.03 · New debt or another financial obligation
- Item 3.02 · Unregistered sale of shares
- Item 9.01 · Financial statements and exhibits
More CODX filings
- 8-K
Filed Nov 19, 2026
- 8-K
Filed Nov 13, 2026
- 10-Q
Filed Nov 10, 2026
- 8-K
Filed Nov 10, 2026
- S-3
Filed Nov 4, 2026
- DEF 14A
Filed Oct 26, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.